Press Releases

 
Press Releases
  Date Title View
Feb 23, 2017
EDAP Announces Preliminary Unaudited Full Year 2016 Revenue Full year 2016 revenue increased to approximately €35.6 million 2016 HIFU revenues recorded over 63% growthStrong cash position of €22 millionCompany to announce fourth quarter and full year 2016 results April 3rd with accompanying conference call April 4th LYON, Fr...
Jan 23, 2017
LYON, France, Jan. 23, 2017 (GLOBE NEWSWIRE) -- EDAP TMS SA (NASDAQ:EDAP), the global leader in therapeutic ultrasound, announced today that it has signed an exclusive agreement with the Canadian company LABORIE to distribute their urodynamic diagnostic products in Japan, one of the largest global markets for urology. Jean-François Bach...
Jan 4, 2017
LYON, France, Jan. 04, 2017 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that it will be hosting meetings with analysts and investors during the JP Morgan Healthcare conference week, January 9th & 10th in San Francisco, CA. Marc Oczachowski will provide an update on the company and wi...
Dec 19, 2016
LYON, France, Dec. 19, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the publication of results comparing Ablatherm Focal HIFU with Robotic Radical Prostatectomy. The results of the study have been electronically published in the prestigious peer-reviewed medical Journal of Endour...
Dec 14, 2016
LYON, France, Dec. 14, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the sale of a Focal One® system to Foch Hospital, Paris, one of the largest private hospitals in the Paris Area. Pr. Thierry Lebret, Head of Urology and Kidney Transplantation Department at Foch Hospita...
Dec 12, 2016
LYON, France, Dec. 12, 2016 (GLOBE NEWSWIRE) -- EDAP TMS S.A. (NASDAQ:EDAP), the global leader in therapeutic ultrasound today announced that it has retained CG Capital, a leading capital markets development and research firm as their new investor relations counsel. Marc Oczachowski, EDAP TMS Chief Executive Officer, commented, "CG Capital's...
Dec 8, 2016
LYON, France, Dec. 08, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the award of the prestigious 2016 Prix Galien, in the Medical Device category, for its Focal One HIFU device dedicated to the treatment of localized prostate cancer. The Prix Galien honors major innovative therap...
Nov 17, 2016
Highlights at the end of September 30, 2016: Total cumulated revenue in 2016  up 22% year-over-year;Driven by HIFU growth, Gross Margin increases to 45%;111% growth in HIFU revenues in Q3 of 2016 compared to Q3 2015;Company continues to show operating profit in 2016 at the end of Q3;Strong cash position of EUR 18.8 million as of September 30, ...
Nov 3, 2016
LYON, France, Nov. 03, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it plans to release financial results for the third quarter ended September 30, 2016 on Thursday, November 17, 2016, during pre-market hours. Company management will host a conference call on Thursday, ...
Oct 11, 2016
LYON, France, Oct. 11, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the results of a multicentric study using Ablatherm Robotic HIFU which demonstrates promising oncologic outcomes with low side effects. The results of the study have been electronically published in the prestigio...
FirstPrevious
2
... NextLast
= add release to Briefcase